$2.82
-0.17-5.69%
At close: -
$2.80
-0.02-0.71%
After Hours: 7:54 PM EDT
Comments
Loading...
AbCellera Biologics (ABCL) Forecast
NewsEarningsAbCellera Biologics (ABCL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAbCellera Biologics (NASDAQ:ABCL) Stock Quotes, Forecast and News Summary
AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AbCellera Biologics (ABCL) stock?
You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.
Who are AbCellera Biologics (ABCL) competitors?
Other companies in AbCellera Biologics’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Quanterix (NASDAQ:QTRX) and Sotera Health (NASDAQ:SHC).
What is the forecast, or price target, for AbCellera Biologics (ABCL) stock?
AbCellera Biologics has a consensus price target of $21.11.
What is the current price for AbCellera Biologics (ABCL)?
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.8 last updated December 30, 2024 at 7:54 PM EST.
Does AbCellera Biologics (ABCL) pay a dividend?
There are no upcoming dividends for AbCellera Biologics.
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics’s Q4 earnings are confirmed for Tuesday, February 18, 2025.
Is AbCellera Biologics (ABCL) going to split?
There is no upcoming split for AbCellera Biologics.
What sector and industry does AbCellera Biologics (ABCL) operate in?
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.